Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Beltrand

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine|October 20, 2020
The antidiabetic drug glibenclamide exerts direct retinal neuroprotectionMarianne Berdugo, Kimberley Delaunay, Marie-Christine Naud, et al.
Diabetes Care|October 7, 2015
Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel MutationsJacques Beltrand, Caroline Elie, Kanetee Busiah, et al.
Diabetes Care|November 13, 2020
Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated <i>ABCC8</i> Permanent Neonatal DiabetesPamela Bowman, Frances Mathews, Fabrizio Barbetti, et al.
European Journal of Endocrinology|December 1, 2011
High prevalence of hirsutism and menstrual disorders in obese adolescent girls and adolescent girls with type 1 diabetes mellitus despite different hormonal profilesDinane Samara-Boustani, Ana Colmenares, Caroline Elie, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 24, 2024
Severe neurodevelopmental phenotype, diagnostic, and treatment challenges in patients with SECISBP2 deficiencyAthanasia Stoupa, Monica Malheiros Franca, Maha Abdulhadi-Atwan, et al.
Pediatric Diabetes|August 15, 2018
The influence of treatment, age at onset, and metabolic control on height in children and adolescents with type 1 diabetes-A SWEET collaborative studyJannet Svensson, Anke Schwandt, Daniele Pacaud, et al.
Hormone Research in Paediatrics|November 8, 2014
Water and electrolyte disorders at long-term post-treatment follow-up in paediatric patients with suprasellar tumours include unexpected persistent cerebral salt-wasting syndromeLaura González Briceño, Jacques Grill, Franck Bourdeaut, et al.
The Lancet. Diabetes & Endocrinology|June 9, 2018
Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort studyPamela Bowman, Åsta Sulen, Fabrizio Barbetti, et al.
Diabetes Technology & Therapeutics|January 23, 2026
Overcoming Closed-Loop System Limits: Diluted Insulin Improves Glycemic Control and Reduces Nighttime Hypoglycemia in Toddlers with Low Insulin RequirementsOlivier G Pollé, Gaëlle Vermillac, Robin Fortier, et al.
The Lancet. Diabetes & Endocrinology|February 26, 2026
Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA<sub>1c</sub> (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trialEmma G Wilmot, Jacques Beltrand, Bruno Guerci, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Translational Research : the Journal of Laboratory and Clinical Medicine|October 20, 2020
The antidiabetic drug glibenclamide exerts direct retinal neuroprotectionMarianne Berdugo, Kimberley Delaunay, Marie-Christine Naud, et al.
Diabetes Care|October 7, 2015
Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel MutationsJacques Beltrand, Caroline Elie, Kanetee Busiah, et al.
Diabetes Care|November 13, 2020
Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated <i>ABCC8</i> Permanent Neonatal DiabetesPamela Bowman, Frances Mathews, Fabrizio Barbetti, et al.
European Journal of Endocrinology|December 1, 2011
High prevalence of hirsutism and menstrual disorders in obese adolescent girls and adolescent girls with type 1 diabetes mellitus despite different hormonal profilesDinane Samara-Boustani, Ana Colmenares, Caroline Elie, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 24, 2024
Severe neurodevelopmental phenotype, diagnostic, and treatment challenges in patients with SECISBP2 deficiencyAthanasia Stoupa, Monica Malheiros Franca, Maha Abdulhadi-Atwan, et al.
Pediatric Diabetes|August 15, 2018
The influence of treatment, age at onset, and metabolic control on height in children and adolescents with type 1 diabetes-A SWEET collaborative studyJannet Svensson, Anke Schwandt, Daniele Pacaud, et al.
Hormone Research in Paediatrics|November 8, 2014
Water and electrolyte disorders at long-term post-treatment follow-up in paediatric patients with suprasellar tumours include unexpected persistent cerebral salt-wasting syndromeLaura González Briceño, Jacques Grill, Franck Bourdeaut, et al.
The Lancet. Diabetes & Endocrinology|June 9, 2018
Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort studyPamela Bowman, Åsta Sulen, Fabrizio Barbetti, et al.
Diabetes Technology & Therapeutics|January 23, 2026
Overcoming Closed-Loop System Limits: Diluted Insulin Improves Glycemic Control and Reduces Nighttime Hypoglycemia in Toddlers with Low Insulin RequirementsOlivier G Pollé, Gaëlle Vermillac, Robin Fortier, et al.
The Lancet. Diabetes & Endocrinology|February 26, 2026
Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA<sub>1c</sub> (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trialEmma G Wilmot, Jacques Beltrand, Bruno Guerci, et al.
Pageof 9